Managing Immunotherapy Treatment Related Rash | NCODA
Written by: Natasha Heimbigner, PharmD, Summit Cancer Centers Download Here Description of PQI: The use of immunotherapy in cancer treatment has expanded tremendously over the last several years. The most common adverse effects include dermatologic, gastrointestinal, hepatic, and endocrine toxicities. Management of immunotherapy-related rash is an important intervention for the patient’s ...
DA: 90 PA: 23 MOZ Rank: 79